Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thiamine as a Renal Protective Agent in Septic Shock: A Randomized, Controlled Study

NCT03550794 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03550794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03550794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thiamine as a Renal Protective Agent in Septic Shock: A Randomized, Controlled Study
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 2
Overall status
Completed
Start date
September 4, 2018
Completion date
April 5, 2022
Enrollment
95 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

kidney injury, sepsis, thiamine deficiency